Remove Innovations Remove Pharmaceutical Remove Portfolios
article thumbnail

JNJ Continues to Grow AD Pipeline With New Licensing Agreement

The Dermatology Digest

Johnson & Johnson has entered into an exclusive licensing agreement for the global development, manufacturing and commercialization of a STAT6 program for autoimmune and allergic diseases, including atopic dermatitis (AD), from Kaken Pharmaceutical. the venture capital organization of Johnson & Johnson.

article thumbnail

10 Best Nasal Sprays for COVID-19 (2023)

Aesthetics Advisor

Moreover, Glenmark Pharmaceuticals received manufacturing and marketing approval for the Nitric Oxide Nasal Spray (NONS) as part of an accelerated approval process. Glenmark Pharmaceuticals has signed a partnership with Canadian company SaNOtize Research & Development Corp., You can purchase it online on Amazon.com.

article thumbnail

"Safe" Beauty E-Summit 2022 Replay!

The Eco Well Blog

Dr M has over 20 years of experience in the pharmaceutical, biopharma and cosmetics industries. His product safety portfolio included: Jergens and Curel lotions, Biore face care, Ban antiperspirant, and John Frieda hair care. Mojgan Moddaresi (Aka DrM) is a regulatory expert and managing director of personal Care Regulatory ltd.

article thumbnail

Sunscreen E-Summit 2022: Replay

The Eco Well Blog

IBA supports creative, innovative companies from startups to established multinational businesses of all sizes succeed in the rapidly changing, highly competitive global cosmetics and personal care industry. His current focus is on Sun care, Color cosmetics and Sustainable innovation. in both Skin Care and Hair Care.

Legal 52